Editorial
The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer
Gianluca Ingrossoa Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia and Perugia General Hospital, Perugia, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-4380-6947View further author information
https://orcid.org/0000-0003-4380-6947View further author information, Andrea Lanciab Department of Radiation Oncology, Policlinico San Matteo Pavia Fondazione IRCCS, Pavia, Italyhttps://orcid.org/0000-0001-6106-7725View further author information
https://orcid.org/0000-0001-6106-7725View further author information, , Antonio Rosario Pisanic Section of Nuclear Medicine, Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italyhttps://orcid.org/0000-0002-3335-9541View further author information
https://orcid.org/0000-0002-3335-9541View further author information, , & show all